Navigation Links
JACC: Cardiovascular Imaging now abstracted and indexed by Thomson Reuters
Date:4/23/2010

New York, NY, 23 April, 2010 -- The American College of Cardiology and Elsevier are proud to announce that JACC: Cardiovascular Imaging has been accepted for coverage by Thomson Reuters (formerly Thomson Scientific/ISI) abstracting and indexing services, including the Journal Citation Reports. The Journal will receive its first impact factor in 2011.

"The Editorial Board and the American College of Cardiology are extremely pleased that the JACC: Cardiovascular Imaging has been accepted by Thomson Reuters," commented Editor-in-Chief Jagat Narula, MD, PhD, FACC. "This coverage will help to further increase dissemination of the journal's content to support our mission to present new knowledge in integrated imaging to enhance patient care."

Abstracting and indexing will begin with Volume 1:1 (2008) in Science Citation Index Expanded (also known as SciSearch), Social Sciences Citation Index, Current Contents/Clinical Medicine and Journal Citation Reports/Science Edition.

JACC: Cardiovascular Imaging publishes papers with direct relevance to patient care and addresses current issues impacting cardiovascular imaging. The editorial board actively encourages submission of original research articles on noninvasive and invasive imaging techniques, including echocardiography (surface, invasive, and interventional), CT, CMR (including spectroscopy), nuclear (including PET), optical imaging, and cine-angiography; advances in basic science and molecular imaging that are likely to substantially influence the clinical practice of medicine in the next decade.

"Coverage by Thomson Reuters clearly acknowledges the high-quality, significant work published in the journal and the continuing efforts of the highly-respected editors, reviewers and the ACC. We at Elsevier would like to thank them all for their contribution to this excellent achievement," stated Elsevier's Cynthia Baudendistel, Executive Publisher, Elsevier.

<
'/>"/>
Contact: Rachael Zaleski
rachael.zaleski@elsevier.com
215-239-3658
Elsevier
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Single Genetic Factor Key to Cardiovascular System
2. Tackling cardiovascular disease surge worldwide requires collaboration
3. AFib Educator app and widget offers patient dialogue tool for complex cardiovascular disease
4. UBC-Providence health team identifies a key predictor of cardiovascular death
5. Antibodies linked to cardiovascular disease increase in patients with active lupus
6. Tiny molecules may tell big story about cardiovascular disease risk
7. Nurses unite to improve cardiovascular practice
8. Early life stress may predict cardiovascular disease
9. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis
10. Childhood obesity alone may increase risk of later cardiovascular disease
11. Long-Term Statin Use Best Way to Cut Cardiovascular Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Chicago, IL (PRWEB) May 20, 2013 ... of innovative cloud and on-premise business process ... version 6.0 of its next-generation integration solution. ... data integration solution that seamlessly automates business ... and reporting with meaningful business user interaction ...
(Date:5/20/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) -- ... out in the late 1990s is more effective than ... contends. Teenagers who received four shots with the ... were 2 years old were significantly less likely to ... in California, compared to children who received all of ...
(Date:5/20/2013)... Mich. As high schoolers prepare for final exams, ... drug" -- a prescription stimulant or amphetamine -- to ... Michigan poll shows only one in 100 parents of ... used a study drug., Study drugs refer to stimulant ... hyperactivity disorder (ADHD); commonly prescribed medicines in this category ...
(Date:5/20/2013)... 20, 2013 Medicare Part D seniors ... citing lower costs, convenient access to pharmacies and other ... Associates released today by the Pharmaceutical Care Management Association ... million) are currently enrolled in plans with preferred networks. ... overall value of plans with preferred pharmacy networks,” said ...
(Date:5/20/2013)... It’s May which means it’s Bike Month! If ... out those dusty bikes and helmets. , Windsong Production's and ... in the office with Windsong Productions challenging ... pledged miles for the 4th Annual Million Mile Challenge. They ... , *insert battle prep montage* , This is all part ...
Breaking Medicine News(10 mins):Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 2Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 3Health News:Study: Older Whooping Cough Vaccine More Effective 2Health News:Study: Older Whooping Cough Vaccine More Effective 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2Health News:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2
... FRIDAY, Nov. 11 (HealthDay News) -- Repeated bouts of ... pain and infertility, a new study says. Pelvic inflammatory ... is marked by inflammation of the reproductive organs. The condition ... year and one in 10 of them becomes infertile, according ...
... CA NOVEMBER 11, 2011 A randomized comparison ... sirolimus delivery from an abluminal biodegradable polymer matrix with ... paclitaxel-eluting stent showed that the dual therapy stent effectively ... and effective. Results of the REMEDEE trial were presented ...
... 2011 A clinical trial of patients with ... arteries found that treatment with paclitaxel-coated balloon angioplasty ... (POBA). Results from the PEPCAD-DES clinical trial were ... Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular ...
... been used to convert atmospheric nitrogen into ammonia, which is ... of the process, scientists have had little understanding of how ... by Patrick Holland of the University of Rochester, has new ... published in the latest issue of Science . ...
... With their teachers, help, children who have been abused can ... study. Researchers from the University of Missouri found that ... kids were those who focused on everyday management skills, such ... teachers to watch for signs and stop the abuse to ...
... in young people on the health of their hearts may ... suicide attempts in people younger than 40, especially young women, ... from a nationwide study have revealed. The results are ... General Psychiatr y. "This is the first study looking ...
Cached Medicine News:Health News:STD Complication May Double Infertility Risk 2Health News:Results of the REMEDEE trial reported at TCT 2011 2Health News:Results of the PEPCAD-DES trial reported at TCT 2011 2Health News:Researchers gain insight into 100-year-old Haber-Bbosch process 2Health News:Teachers Critical in Helping Abused Kids Succeed 2Health News:Depression in young people increases risk of heart disease mortality 2
(Date:5/20/2013)... ROCKVILLE, Md. , May 20, 2013  Neuralstem, ... Eva Feldman , MD, PhD, principal investigator, presented ... neural stem cell (NSI-566) trial in the treatment of ... ,s disease) at the neuro diabetes special medical ... Friday. In a talk called "Recent Therapeutic Advances in ...
(Date:5/20/2013)... , May 20, 2013 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that ... offering a greater effect on quality of life ... Given the high level of subjectivity and variability ... interviewed thought leaders state that it is difficult ...
(Date:5/19/2013)... 20, 2013  Whole-cell pertussis vaccines were more effective ... a large recent outbreak, according to a new Kaiser ... vaccines, also called DTwP, were available from the 1940s ... ultimately led to the development of acellular pertussis vaccines, ... the United States had switched ...
Breaking Medicine Technology:Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4
... , , TITUSVILLE, ... U.S. Food and Drug Administration approved INVEGA(R) SUSTENNA(TM) (paliperidone ... treatment of schizophrenia in adults on Friday, July 31, ... antipsychotic approved in the U.S. for this use. Janssen((R)), ...
... NEW YORK, July 29 Grammy-Award winning artist and ... to create an exclusive (RED)ZONE seating section for his August 13th, ... Beginning July 29th, every purchase at select Gap stores in the ... shoppers to obtain one ticket in the reserved RED(ZONE) section for ...
Cached Medicine Technology:Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 2Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 3Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 4Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 5Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 6Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 7Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 8Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 9John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden 2John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: